Ensysce Biosciences, Inc. (ENSC) Operating income 2018–2025
Ensysce Biosciences, Inc. (ENSC) annual operating income history from SEC filings — each fiscal year as reported.
-$10.2MFY2025 · since FY2018: -$959,240 → -$10.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.2M | -52.2% |
| FY2024 | -$6.7M | +37.2% |
| FY2023 | -$10.7M | +55.8% |
| FY2022 | -$24.2M | -21.9% |
| FY2021 | -$19.9M | -1131.7% |
| FY2020 | -$1.6M | +51.5% |
| FY2019 | -$3.3M | -247.0% |
| FY2018 | -$959,240 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENSC financial trends
ENSC RevenueENSC Net incomeENSC Net marginENSC Gross profitENSC Gross marginENSC Operating marginENSC Operating cash flowENSC Free cash flowENSC Capital expendituresENSC Return on equityENSC Stock buybacksENSC Dividends paidENSC Total assetsENSC Total liabilitiesENSC Shareholders’ equityENSC overview →